Kolexia
Madranges Nicolas Oncologie médicale
Madranges Nicolas
Oncologie médicale
Centre Hospitalier Libourne
Libourne, France
45 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Métastase tumorale Tumeurs du sein triple-négatives Carcinome canalaire du sein Effets secondaires indésirables des médicaments Tumeurs osseuses Tumeur du sein de l'homme Inflammation muqueuse Carcinome lobulaire

Collaborateurs

Voir plus
Debled Marc
Debled Marc
Institut Bergonié, Bordeaux, France
Breton-Callu Christel
Breton-Callu Christel
Centre Hospitalier de Brive, Brive-la-Gaillarde, France
Kamsu Kom Leopold
Kamsu Kom Leopold
Centre Hospitalier de Brive, Brive-la-Gaillarde, France
Dalenc Florence
Dalenc Florence
Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France

Industries

Voir plus
Lilly
9 collaboration(s)
Dernière en 2023
AstraZeneca
8 collaboration(s)
Dernière en 2023
Novartis
5 collaboration(s)
Dernière en 2023
Amgen
4 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
PROLIFE: Quality of Life and Economic Repercussions of Combining Proactive Medication Assessment and Electronic Monitoring of Toxicities in Subjects Undergoing Oral Cancer Therapy
Essai Clinique (CHU Nîmes)   13 novembre 2023
AMA: A Phase II Trial Evaluating the Activity of Abiraterone Acetate Plus Prednisone in Patients With a Molecular Apocrine HER2-negative Locally Advanced or Metastatic Breast Cancer
Essai Clinique (Unicancer)   21 février 2021
Real-world Evaluation of Oral Vinorelbine in the Treatment of Metastatic Breast Cancer: An ESME-MBC Study.
Anticancer research   05 août 2020
Severe rhabdomyolysis induced by possible drug-drug interaction between Ribociclib and Simvastatin.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners   29 juillet 2020
Radiation therapy to the primary tumor for de novo metastatic breast cancer and overall survival in a retrospective multicenter cohort analysis.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology   10 janvier 2020
Survival Impact of Locoregional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancers in a Large Multicentric Cohort Study: A Propensity Score-Matched Analysis.
Annals of surgical oncology   11 décembre 2018
A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1).
Annals of oncology : official journal of the European Society for Medical Oncology   18 février 2016
Efficacy and tolerance of everolimus in 123 consecutive advanced ER positive, HER2 negative breast cancer patients. A two center retrospective study.
Breast (Edinburgh, Scotland)   19 septembre 2015
Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally advanced hormone-receptor-positive breast cancer.
British journal of cancer   14 juillet 2015
Treatment patterns, clinical outcomes and health care costs associated with HER2-positive breast cancer with central nervous system metastases: a French multicentre observational study.
BMC health services research   31 octobre 2013